000 01315 a2200337 4500
005 20250516161726.0
264 0 _c20140317
008 201403s 0 0 eng d
022 _a1531-703X
024 7 _a10.1097/CCO.0b013e328363df0b
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerrero, Simone
245 0 0 _aThe current therapeutic scenario for relapsed mantle cell lymphoma.
_h[electronic resource]
260 _bCurrent opinion in oncology
_cSep 2013
300 _a452-62 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAlgorithms
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aLymphoma, Mantle-Cell
_xtherapy
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aRecurrence
700 1 _aDreyling, Martin
773 0 _tCurrent opinion in oncology
_gvol. 25
_gno. 5
_gp. 452-62
856 4 0 _uhttps://doi.org/10.1097/CCO.0b013e328363df0b
_zAvailable from publisher's website
999 _c22934800
_d22934800